节球毒素结构式
|
常用名 | 节球毒素 | 英文名 | Nodularin |
---|---|---|---|---|
CAS号 | 118399-22-7 | 分子量 | 824.963 | |
密度 | 1.3±0.1 g/cm3 | 沸点 | N/A | |
分子式 | C41H60N8O10 | 熔点 | N/A | |
MSDS | 中文版 美版 | 闪点 | 11℃ | |
符号 |
GHS02, GHS06, GHS08 |
信号词 | Danger |
中文名 | 节球毒素 |
---|---|
英文名 | (2Z,5R,6S,9S,12S,13S,16R)-9-[3-(diaminomethylideneamino)propyl]-2-ethylidene-12-[(1E,3E,5S,6S)-6-methoxy-3,5-dimethyl-7-phenylhepta-1,3-dienyl]-1,6,13-trimethyl-3,7,10,14,19-pentaoxo-1,4,8,11,15-pentazacyclononadecane-5,16-dicarboxylic acid |
英文别名 | 更多 |
密度 | 1.3±0.1 g/cm3 |
---|---|
分子式 | C41H60N8O10 |
分子量 | 824.963 |
闪点 | 11℃ |
精确质量 | 824.443237 |
PSA | 282.44000 |
LogP | -0.56 |
折射率 | 1.598 |
储存条件 | −20°C |
水溶解性 | methanol: 2 mg/mL Further dilute to 10% (v/v) methanol. Store solutions at −20°C for up to six months. |
更多 | 1. 性状:无可用 2. 密度(g/mL,25/4℃):无可用 3. 相对蒸汽密度(g/mL,空气=1):无可用 计算化学数据 纠错 | 编辑1.疏水参数计算参考值(XlogP):1.7 2.氢键供体数量:8 3.氢键受体数量:11 4.可旋转化学键数量:13 5.互变异构体数量:216 6.拓扑分子极性表面积285 7.重原子数量:59 8.表面电荷:0 9.复杂度:1620 10.同位素原子数量:0 11.确定原子立构中心数量:8 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:3 14.不确定化学键立构中心数量:0 15.共价键单元数量:1 |
符号 |
GHS02, GHS06, GHS08 |
---|---|
信号词 | Danger |
危害声明 | H225-H301 + H311 + H331-H370 |
警示性声明 | P210-P260-P280-P301 + P310-P311 |
个人防护装备 | Eyeshields;Faceshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US) |
危害码 (欧洲) | T: Toxic; |
风险声明 (欧洲) | 23/24/25-38 |
安全声明 (欧洲) | 36/37-45 |
危险品运输编码 | UN 2811 6.1/PG 2 |
WGK德国 | 3 |
RTECS号 | GU2294250 |
~% 节球毒素 118399-22-7 |
文献:Journal of Medicinal Chemistry, , vol. 52, # 18 p. 5759 - 5762 |
~% 节球毒素 118399-22-7 |
文献:Journal of Medicinal Chemistry, , vol. 52, # 18 p. 5759 - 5762 |
节球毒素上游产品 2 | |
---|---|
节球毒素下游产品 0 |
Biological treatment options for cyanobacteria metabolite removal--a review.
Water Res. 46(5) , 1536-48, (2012) The treatment of cyanobacterial metabolites can consume many resources for water authorities which can be problematic especially with the recent shift away from chemical- and energy-intensive processe... |
|
Simultaneous detection of nine cyanotoxins in drinking water using dual solid-phase extraction and liquid chromatography-mass spectrometry.
Toxicon 58(2) , 209-18, (2011) A solid-phase extraction (SPE)-liquid chromatography (LC)-mass spectrometry (MS) method was developed to concentrate and detect nine cyanotoxins simultaneously, including six microcystins (MCs) congen... |
|
Tumor promoters--microcystin-LR, nodularin and TNF-α and human cancer development.
Anticancer Agents Med. Chem. 11(1) , 4-18, (2011) Microcystin-LR and nodularin, along with okadaic acid, are potent inhibitors of protein phosphatases 1 and 2A (PP1 and PP2A). The mechanisms of action of microcystin-LR and nodularin in the liver and ... |
(2Z,5R,6S,9S,12S,13S,16R)-9-{3-[(diaminomethylidene)amino]propyl}-2-ethylidene-12-[(1E,3E,5S,6S)-6-methoxy-3,5-dimethyl-7-phenylhepta-1,3-dien-1-yl]-1,6,13-trimethyl-3,7,10,14,19-pentaoxo-1,4,8,11,15-pentaazacyclononadecane-5,16-dicarboxylic acid |
Nodularin |
(2Z,5R,6S,9S,12S,13S,16R)-9-(3-Carbamimidamidopropyl)-2-ethylidene-12-[(1E,3E,5S,6S)-6-methoxy-3,5-dimethyl-7-phenyl-1,3-heptadien-1-yl]-1,6,13-trimethyl-3,7,10,14,19-pentaoxo-1,4,8,11,15-pentaazacyclononadecane-5,16-dicarboxylic acid |
1,4,8,11,15-Pentaazacyclononadecane-5,16-dicarboxylic acid, 9-[3-[(aminoiminomethyl)amino]propyl]-2-ethylidene-12-[(1E,3E,5S,6S)-6-methoxy-3,5-dimethyl-7-phenyl-1,3-heptadien-1-yl]-1,6,13-trimethyl-3,7,10,14,19-pentaoxo-, (2Z,5R,6S,9S,12S,13S,16R)- |
Nodularin solution |
1,4,8,11,15-Pentaazacyclononadecane,cyclic peptide |
MFCD00165004 |
1,4,8,11,15-pentaazacyclononadecane-5,16-dicarboxylic acid, 9-[3-[(diaminomethylene)amino]propyl]-2-ethylidene-12-[(1E,3E,5S,6S)-6-methoxy-3,5-dimethyl-7-phenyl-1,3-heptadien-1-yl]-1,6,13-trimethyl-3,7,10,14,19-pentaoxo-, (2Z,5R,6S,9S,12S,13S,16R)- |